Educational notice: This guide is for general informational purposes only. It is not medical advice and does not diagnose, treat, cure, or prevent any disease. Consult a licensed clinician if you are pregnant, nursing, have a medical condition, or take medications.
Quick take
- What it is: A eugeroic wakefulness compound; bisfluoro analog of adrafinil (CRL-40,941).
- What it may support: Alertness and sustained focus on demanding days (individual results vary).
- Evidence level: Limited human data on fladrafinil; modafinil is the best-studied related compound.
- How to use: 20mg, morning only, 2-4 times per week max.
- Quality signal: 99% HPLC purity (CRL-40,941), BTLabs-signed COA on file.
| Onset | Duration | Timing | Form |
|---|---|---|---|
| 30-60 minutes | 6-8 hours (reported) | AM only, before 10am | 20mg capsules (30 / 60 / 100 count) |
View Fladrafinil 20mg Capsules
Contents
- What is fladrafinil?
- How fladrafinil may work (mechanism)
- What the evidence shows (and what it does not)
- Dosing and timing
- Safety, side effects, and who should avoid
- Legality notes (UAE and beyond)
- COA and batch verification
- FAQ
What Is Fladrafinil?
Fladrafinil is a eugeroic: a compound discussed for promoting wakefulness without the classic jitter associated with stimulants like caffeine or amphetamines. It belongs to the same compound family as adrafinil and modafinil, wakefulness-promoting agents developed for daytime alertness research.
Chemically, fladrafinil is known as CRL-40,941, a bisfluoroadrafinil structural analog of adrafinil. That structural relationship places it in a well-known class of eugeroics, even though fladrafinil itself has far less human clinical data than modafinil.
Important context: fladrafinil is not an approved medicine in most jurisdictions. It is not a substitute for prescription wakefulness agents, and it should not be used to treat narcolepsy, ADHD, sleep apnea, or any other medical condition.
People typically explore Fladrafinil 20mg capsules when they want occasional support for alertness on high-demand work or study days, not as a daily cognitive shortcut.
What fladrafinil is not:
- Not a cognitive enhancer: It may support wakefulness and the ability to stay on task. The thinking is still yours.
- Not for daily use: Used too often, the effect may fade and sleep may suffer. Save it for days that genuinely demand it.
- Not an evening tool: Duration is long. Take it late and sleep disruption is likely.
How Fladrafinil May Work (Mechanism)
Mechanism descriptions for fladrafinil are largely inferred from the eugeroic class and preclinical pharmacology, not from robust fladrafinil human trials. The responsible framing is: these pathways are discussed in the literature for related compounds and may apply to fladrafinil, but direct confirmation in humans is limited.
| Pathway | What literature discusses | Hedged framing |
|---|---|---|
| Dopamine | Modulation of dopaminergic signaling linked to motivation and alertness | May influence dopamine pathways associated with wakefulness |
| Orexin / hypocretin | Orexin system regulates sleep-wake transitions | May act on orexin-related wakefulness circuits |
| Histamine | Histaminergic tone supports daytime alertness | May support histamine-mediated alertness |
Not a classic stimulant: Caffeine and amphetamines often push arousal through adrenergic pathways. Eugeroics are discussed as promoting wakefulness through different neurotransmitter routes. The practical difference many users report: alertness without a racing heart or wired edge.
Not a cognitive enhancer in the clinical sense: Fladrafinil may help you stay on task by reducing sleep pressure, but it does not guarantee improved memory, IQ, or learning outcomes. The thinking is still yours.
What mechanism claims do NOT mean:
- Does not treat narcolepsy, ADHD, or sleep disorders
- Does not guarantee improved IQ or memory
- Does not prove equivalence to modafinil in potency or duration
What the Evidence Shows (and What It Does Not)
Tier A: Best available human data (modafinil proxy only)
Modafinil meta-analyses suggest task-specific attention and working memory effects in some healthy adults, with mixed results in well-rested subjects. These are the strongest human data points for the eugeroic class. [Ref 1, Ref 2]
Explicit caveat: these studies are on modafinil, not fladrafinil. They inform what the broader eugeroic class may do; they do not prove identical effects for fladrafinil.
Tier B: Fladrafinil-specific evidence
- Very limited published human clinical trials on fladrafinil itself
- Mostly preclinical pharmacology and community reports
- No robust RCT body to support broad cognitive or disease-treatment claims
| Known / discussed | Unknown / unproven |
|---|---|
| Eugeroic class wakefulness effects (modafinil data) | Long-term fladrafinil human safety |
| Anecdotal reports of alertness without caffeine jitters | Standardized clinical dosing for fladrafinil |
| Structural relationship to adrafinil and modafinil | Disease treatment efficacy |
| Preclinical pharmacology exists | Direct 1:1 potency vs modafinil |
Dosing and Timing
The following reflects common product labeling and community practice. It is conceptual guidance, not a medical protocol. Individual responses vary.
Standard starting approach:
- Dose: 1 capsule = 20mg; start with one to assess personal response
- When: Early morning, ideally before 10am
- Duration of effect: Commonly reported 6-8 hours
- Frequency: Limit to 2-4 times per week; not for daily use
- Hydration / meals: Wakefulness may mask hunger and thirst cues; eat and drink normally
Practical rules:
- Do not redose the same day without understanding your response
- Do not take in the afternoon or evening (sleep disruption risk)
- Occasional use helps maintain effect; daily use may reduce benefit and affect sleep
Community sources (non-clinical): Some forums discuss 40-100mg ranges. Nootropix sells pre-labeled 20mg caps specifically to reduce dosing errors. Always start at the lowest labeled dose.
Our Fladrafinil 20mg Capsules are pre-measured to remove guesswork.
Shop Fladrafinil 20mg Capsules
Safety, Side Effects, and Who Should Avoid
Fladrafinil is not risk-free. Commonly reported effects may include:
- Headache
- Insomnia (especially if taken late)
- Reduced appetite
- Restlessness or anxiety in sensitive users
- Tolerance with frequent use
Risk flags:
- Late-day dosing
- Daily or near-daily use
- Stacking with caffeine, other stimulants, or racetams without assessing baseline response
- Pre-existing sleep disorders, cardiovascular conditions, or psychiatric instability
Who should avoid:
- Anyone under 18
- Pregnant or nursing individuals
- Anyone on prescription stimulants, modafinil, or MAOIs without clinician guidance
- People seeking treatment for narcolepsy, ADHD, or sleep apnea (consult qualified care instead)
- First-time users who must drive or operate machinery before assessing personal response
If you take any prescription medication, consult a clinician before use.
Legality Notes (UAE and Beyond)
Regulatory status varies by country. Verify local rules before ordering, importing, or traveling with any compound. This section is general education, not legal advice.
Modafinil is prescription-only in many jurisdictions, including the UAE. Fladrafinil is a separately regulated compound and should not be framed as a "legal modafinil replacement." Treat it as its own category and confirm compliance with local regulations.
For a side-by-side comparison of modafinil, adrafinil, and fladrafinil (evidence, onset, feel, and UAE access), see our Fladrafinil vs Modafinil vs Adrafinil guide.
COA and Batch Verification
When human trial data is thin, purity and identity verification become the quality signal. A Certificate of Analysis (COA) confirms that what is in the capsule matches the labeled compound and meets stated purity thresholds.
Nootropix COA on file (BTLabs, report IF-824-QSA-TR006-2025-100-02):
- Testing material: CRL-40,941 (fladrafinil)
- Date tested: Oct 27, 2025
- BT Sample ID: 005000036406340
- HPLC purity: 99% (specification: 98% or higher)
- FTIR identity: Spectrum confirms CRL-40,941 with excipient/filler (mannitol noted on report)
- Lab: BTLabs, West Palm Beach, FL (independent third-party testing)
- Signed by: Kimberly Quinn, MS (Lab Manager) and Andrea Castro, AS (Scientist-I)
The COA applies to the sample as received and tested. It covers identification and HPLC purity; it does not report microbial contamination or endotoxin testing. Match your unit to the COA on the product page or request the report by sample ID when buying from any vendor.
What to check on any fladrafinil product:
- Identity matches CRL-40,941
- HPLC purity percentage stated
- Independent lab name (not self-reported only)
- Batch/lot number ties your unit to a specific test
- Label shows exact mg per capsule
Nootropix Fladrafinil 20mg Capsules are in stock with batch COA on the product page. From 275 AED. Ships same day from Dubai.
Shop Fladrafinil 20mg Capsules
For related in-stock focus tools, browse the Focus collection.
FAQ
What is fladrafinil?
Fladrafinil (CRL-40,941) is a eugeroic compound structurally related to adrafinil and modafinil. It is discussed for occasional wakefulness support, not as an approved medicine. See What Is Fladrafinil? above.
How does fladrafinil work?
Mechanism descriptions are largely inferred from the eugeroic class. It may influence dopamine, orexin, and histamine pathways associated with wakefulness. See How Fladrafinil May Work for details.
What is the recommended fladrafinil dose?
Start with one 20mg capsule in the morning, ideally before 10am. Limit use to 2-4 times per week. Do not use daily. See Dosing and Timing.
Is fladrafinil safe?
It is not risk-free. Reported side effects may include headache, insomnia, reduced appetite, and restlessness. See Safety, Side Effects, and Who Should Avoid.
Is fladrafinil legal in the UAE?
Regulatory status varies by country and can change. Verify local rules before ordering or traveling with compounds. This is general education, not legal advice.
How is Nootropix fladrafinil tested?
BTLabs report IF-824-QSA-TR006-2025-100-02 (dated Oct 27, 2025) shows 99% HPLC purity for CRL-40,941, with FTIR identity confirmation. COA details are on the product page.
This is education, not medical advice. These statements have not been evaluated by regulatory authorities and are not intended to diagnose, treat, cure, or prevent any disease. Not for use by anyone under 18, pregnant, or nursing. Consult a qualified clinician if you take other medication or have a health condition.
